Monitoring micrornas using a molecular beacon in CD133+/CD338+ human lung adenocarcinoma-initiating A549 cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 161-166

  Yao, Quan ^a   Sun, Jian Guo ^b   Ma, Hu ^c   Zhang, An Mei ^b   Lin, Sheng ^d   Zhu, Cong Hui ^b   Zhang, Tao ^a   Chen, Zheng Tang ^b  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c ZUNYI MEDICAL UNIVERSITY   (China)

^d SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

MicroRNA; Molecular beacon; Molecular imaging; Non small cell lung cancer; Tumor initiating cell

Indexed keywords

ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; MICRORNA; MIRN155 MICRORNA, HUMAN; PEPTIDE; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER STEM CELL; CHEMISTRY; CONFOCAL MICROSCOPY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOMAGNETIC SEPARATION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; TUMOR CELL LINE;

ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; IMMUNOMAGNETIC SEPARATION; LUNG NEOPLASMS; MICRORNAS; MICROSCOPY, CONFOCAL; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 84894024380     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.161     Document Type: Article

References (51)

1. Adhikari AS, Agarwal N, Iwakuma T (2011). Metastatic potential of tumor-initiating cells in solid tumors. Front Biosci, 16, 1927-38.
2. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
3. Bertolini G, Roz L, Perego P, et al (2009). Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA, 106, 16281-6.
4. Bushati N, Cohen SM (2007). microRNA functions. Annu Rev Cell Dev Biol, 23, 175-205.
5. Chen CZ (2005). MicroRNAs as oncogenes and tumor suppressors. N Engl J Med, 353, 1768-71.
6. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 65, 10946-51.
7. Donnem T, Eklo K, Berg T, et al (2011). Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med, 9, 6.
8. Elton TS, Selemon H, Elton SM, Parinandi NL (2012). Regulation of the MIR155 host gene in physiological and pathological processes. Gene, 532, 1-12
9. Eramo A, Lotti F, Sette G, et al (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ, 15, 504-14.
10. Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009). miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta, 1792, 497-505.
11. Garofalo M, Croce CM (2011). microRNAs: Master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol, 51, 25-43.
12. Garzon R, Calin GA, Croce CM (2009). MicroRNAs in Cancer. Annu Rev Med, 60, 167-79.
13. Georgantas RW, Hildreth R, Morisot S, et al (2007). CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA, 104, 2750-5.
14. Greither T, Grochola LF, Udelnow A, et al (2010). Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer, 126, 73-80.
15. Guo W, Lasky JL, Wu H (2006). Cancer stem cells. Pediatr Res, 59, 59-64.
16. Habbe N, Koorstra JB, Mendell JT, et al (2009). MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther, 8, 340-6.
17. Hatfield S, Ruohola-Baker H (2008). microRNA and stem cell function. Cell Tissue Res, 331, 57-66.
18. Henschke CI, Yankelevitz DF, Libby DM, et al (2006). Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med, 355, 1763-71.
19. Hermann PC, Huber SL, Herrler T, et al (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1, 313-23.
20. Ho MM, Ng AV, Lam S, Hung JY (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res, 67, 4827-33.
21. Jemal A, Siegel R, Ward E, et al (2006). Cancer statistics, 2006. CA Cancer J Clin, 56, 106-30.
22. Jiang S, Zhang HW, Lu MH, et al (2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 70, 3119-27.
23. Juan D, Alexe G, Antes T, et al (2010). Identification of a microRNA panel for clear-cell kidney cancer. Urology, 75, 835-41.
24. Kim Y, Yang CJ, Tan W (2007). Superior structure stability and selectivity of hairpin nucleic acid probes with an L-DNA stem. Nucleic Acids Res, 35, 7279-87.
25. Kong W, He L, Coppola M, et al (2010). MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem, 285, 17869-79.
26. Krol J, Loedige I, Filipowicz W (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11, 597-610.
27. Kwak PB, Iwasaki S, Tomari Y (2010). The microRNA pathway and cancer. Cancer Sci, 101, 2309-15.
28. Kwon MJ, Shin YK (2013). Regulation of ovarian cancer stem cells or tumor-initiating cells. Int J Mol Sci, 14, 6624-48.
29. Meng X, Li M, Wang X, Wang Y, Ma D (2009). Both CD133+ and CD133-subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci, 100, 1040-6.
30. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-10.
31. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al (2007). Identification and expansion of human colon-cancer-initiating cells. Nature, 445, 111-5.
32. Ryu JK, Hong SM, Karikari CA, et al (2010). Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology, 10, 66-73.
33. Santangelo P, Nitin N, Bao G (2006). Nanostructured probes for RNA detection in living cells. Ann Biomed Eng, 34, 39-50.
34. Seo DC, Sung JM, Cho HJ, et al (2007). Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer, 6, 75.
35. Singh SK, Clarke ID, Terasaki M, et al (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res, 63, 5821-8.
36. Singh SK, Hawkins C, Clarke ID, et al (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401.
37. + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun, 351, 820-824.
38. Sullivan JP, Minna JD, Shay JW (2010). Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev, 29, 61-72.
39. Tyagi S, Bratu DP, Kramer FR (1998). Multicolor molecular beacons for allele discrimination. Nat Biotechnol, 16, 49-53.
40. Tyagi S, Kramer FR (1996). Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol, 14, 303-8.
41. Wang B, Majumder S, Nuovo G, et al (2009a). Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology, 50, 1152-61.
42. Wang QZ, Xu W, Habib N, Xu R (2009b). Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets, 9, 572-94.
43. Wu K, Ding J, Chen C, et al (2012). Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology, 56, 2255-67.
44. Xie Y, Todd NW, Liu Z, et al (2010). Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer, 67, 170-6.
45. Yanaihara N, Caplen N, Bowman E, et al (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-98.
46. Yao Q, Zhang AM, Ma H, et al (2012). Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer. Mol Cell Probes, 26, 182-7.
47. Yin S, Li J, Hu C, et al (2007). CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer, 120, 1444-50.
48. Yu F, Deng H, Yao H, et al (2010). Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene, 29, 4194-204.
49. Yu F, Jiao Y, Zhu Y, et al (2012). MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem, 287, 465-73.
50. Zandberga E, Kozirovskis V, Abols A, et al (2013). Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer, 52, 356-69.
51. Zhou S, Schuetz JD, Bunting KD, et al (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med, 7, 1028-34.